poisar

Stocks · News reference

JP Morgan Maintains Overweight on MetLife, Raises Price Target to $108

Benzinga Newsdesk

JP Morgan analyst Pablo Singzon maintains MetLife (NYSE:MET) with a Overweight and raises the price target from $106 to $108.

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

MET
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  2. Na

    Can MetLife's Group Benefits Segment Maintain Its Momentum?

    MetLife's Group Benefits segment reported 25% year-over-year earnings growth in Q2 2026, driven by volume growth and improved underwriting. Group Life's mortality ratio improved to 79%, below the 83%-88% target range. However, some mortality benefits may not persist as about 2 percentage points reflected prior-period development. Competitors The Hartford and Aflac showed mixed results, with Hartford's employee benefits expanding but facing higher disability loss ratios, while Aflac's earnings declined despite sales growth.

    METMETPAMETPEMETPFHIG